Abstract

Background:In the past two decades, Vitamin K has been receiving more attention due to its role in bone health and metabolism. The bone mineral density does not remain steady with age, particularly declining after menopause.Objective: This study is aimed to investigate the relationship between bone mineral density and serum vitamin K1 levels in post-menopausal women, and to evaluate serum vitamin K1 levels as a potential biomarker for postmenopausal osteoporosis.Methods:Serum levels of vitamin k1 were measured in 23 postmenopausal osteoporotic women, and in 15 postmenopausal healthy control women using a standardized Enzyme-Linked Immune Sorbent Assay (ELISA) kit. Bone mineral density BMD was assessed at the lumbar spine.Results:The mean serum vitamin k1 level was significantly lower in the postmenopausal osteoporotic women group than in the normal control group (mean=0.794 vs3.61ng/ml, P< 0.0001), and serum vitamin k1 concentration was positively correlated with lumbar spine BMD among postmenopausal osteoporotic women (R=0.533, p = 0.009), and in postmenopausal healthy control (R=0.563, p = 0.02).Diagnostic sensitivity and specificity of vitamin k1 for osteoporosis were 90% and 98%, respectively (cut-off value: 0.853 ng/ml). The area under the ROC curve (AUC) value for vitamin k1 was 0.984 the odd ratio result was 18.66.Conclusion:Our results suggest that vitamin K1 may contribute to maintain bone mineral density. Vitamin K1 may have a role in diagnosing post-menopausal osteoporosis. Vitamin K1 may be a valuable diagnostic as well as therapeutic marker in post-menopausal osteoporosis.

Highlights

  • Osteoporosis is a metabolic bone disease of reduced bone density, fragile bone and heightened vulnerability to fracture [1]

  • We compared serum levels of vitamin K1 between osteoporotic women and healthy control women, and we investigated the relationship between levels of vitamin K1 with bone mineral density in postmenopausal women

  • Post-menopausal women with osteoporosis had significantly lower levels of vitamin K1 than women with normal bone density (P

Read more

Summary

Introduction

Osteoporosis is a metabolic bone disease of reduced bone density, fragile bone and heightened vulnerability to fracture [1]. Bone remodeling is a succession of bone resorption by osteoclasts and bone formation by osteoblasts. Osteoclastic bone resorption and osteoblastic bone formation usually happen at the same rate and it keeps the bone mass constant. Bone mineral density loss with age and osteoporosis is due to exceeding osteoclastic bone resorption without the parallel quantity of bone formation by osteoblasts. Bones reach their maximum density between 20 and 30 years of age, peak bone mass remains at the same level until the age of around 40 years, and it gradually decreases up to the menopause, after which it drops [3]. The bone mineral density does not remain steady with age, declining after menopause

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call